(Q44825279)

6 December 2017

title

A randomized controlled trial of colchicine plus ursodiol versus methotrexate plus ursodiol in primary biliary cirrhosis: ten-year results (English)

1 reference

randomized controlled trial

6 December 2017

1 reference

1 reference

primary biliary cholangitis

inferred from title

0 references

1 reference

Marshall M Kaplan

1

1 reference

6 December 2017

Steven Cheng

series ordinal

2

1 reference

6 December 2017

Lori Lyn Price

series ordinal

3

1 reference

6 December 2017

Peter A L Bonis

series ordinal

4

1 reference

6 December 2017

language of work or name

English

0 references

publication date

1 April 2004

1 reference

6 December 2017

1 reference

6 December 2017

volume

39

1 reference

6 December 2017

issue

4

1 reference

6 December 2017

page(s)

915-923

1 reference

Primary biliary cirrhosis

6 December 2017

cites work

1 reference

7 January 2021

Predictive factors in ursodeoxycholic acid-treated patients with primary biliary cirrhosis: role of serum markers of connective tissue

1 reference

7 January 2021

Ursodeoxycholic acid in the treatment of primary biliary cirrhosis

1 reference

7 January 2021

Randomised controlled trials of ursodeoxycholic-acid therapy for primary biliary cirrhosis: a meta-analysis

1 reference

7 January 2021

Ursodeoxycholic acid for primary biliary cirrhosis: lesson for the future?

1 reference

7 January 2021

A prospective trial of colchicine for primary biliary cirrhosis

1 reference

7 January 2021

Ten-year combination treatment with colchicine and ursodeoxycholic acid for primary biliary cirrhosis: a double-blind, placebo-controlled trial on symptomatic patients.

1 reference

7 January 2021

A randomized trial comparing colchicine and ursodeoxycholic acid combination to ursodeoxycholic acid in primary biliary cirrhosis. UDCA-PBC Study Group

1 reference

7 January 2021

Low-dose methotrexate is ineffective in primary biliary cirrhosis: long-term results of a placebo-controlled trial

1 reference

7 January 2021

Methotrexate therapy for primary biliary cirrhosis

1 reference

7 January 2021

A multicenter, controlled trial of ursodiol for the treatment of primary biliary cirrhosis. UDCA-PBC Study Group

1 reference

7 January 2021

A prospective trial of colchicine and methotrexate in the treatment of primary biliary cirrhosis

1 reference

7 January 2021

Primary Biliary Cirrhosis Treated with Low-Dose Oral Pulse Methotrexate

1 reference

7 January 2021

Effects of ursodeoxycholic acid on survival in patients with primary biliary cirrhosis

1 reference

7 January 2021

Prognosis in primary biliary cirrhosis: model for decision making

1 reference

7 January 2021

Utilization of the Mayo risk score in patients with primary biliary cirrhosis receiving ursodeoxycholic acid

1 reference

7 January 2021

Long-term effects of ursodeoxycholic acid in primary biliary cirrhosis: results of a double-blind controlled multicentric trial. UDCA-Cooperative Group from the Spanish Association for the Study of the Liver

1 reference

7 January 2021

Ten-year survival in ursodeoxycholic acid-treated patients with primary biliary cirrhosis. The UDCA-PBC Study Group

1 reference

7 January 2021

A one-year trial of lamivudine for chronic hepatitis B. Asia Hepatitis Lamivudine Study Group.

1 reference

7 January 2021

A prospective trial of D-penicillamine in primary biliary cirrhosis

1 reference

7 January 2021

Time course of histological progression in primary biliary cirrhosis

1 reference

7 January 2021

Characterisation of patients with a complete biochemical response to ursodeoxycholic acid

1 reference

7 January 2021

Characterisation of patients with primary biliary cirrhosis responding to long term ursodeoxycholic acid treatment

1 reference

7 January 2021

Methotrexate-induced liver cirrhosis. A follow-up.

1 reference

7 January 2021

Identifiers

DOI

10.1002/HEP.20103

1 reference

6 December 2017

1 reference